Atlas Trials

A Single-Center Trial of Intravitreous Injections of Macugen (Pegaptanib Sodium) Given at Least 7 Days Before Vitrectomy Secondary To Tractional Retinal Detachment in Proliferative Diabetic Retinopathy

Clinical trial NCT01487070 · COMPLETED

Trial details

NCT number
NCT01487070
Sponsor
Retina Institute of Hawaii
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
PDR
Start date
2011-04-01
Primary completion
2011-07-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.